Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Nadolol
Related Products

Hot Products

Basic Information Post buying leads Suppliers Cas Database
Name

Nadolol

 EINECS 255-706-3
CAS No. 42200-33-9 Density 1.19 g/cm3
PSA 81.95000 LogP 1.02570
Solubility 8.30g/L(25 oC) Melting Point 125-130 °C
Formula C17H27NO4 Boiling Point 526.437 °C at 760 mmHg
Molecular Weight 309.406 Flash Point 272.179 °C
Transport Information N/A Appearance White Solid
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 42200-33-9 (Nadolol) Hazard Symbols N/A
Synonyms

Anabet;Corgard;SQ 11725;Solgol;2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, cis-;(2R,3S)-5-{[(2R)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-1,2,3,4-tetrahydronaphthalene-2,3-diol;

Article Data 4

Nadolol Synthetic route

copper(II) choride dihydrate

124-38-9

carbon dioxide

42200-33-9

nadolol

1152675-95-0

Na[Cu(5-[3-(tert-butylamino)-2-oxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol)CO3)*H2O

Conditions
ConditionsYield
With NaOH In water 1 equiv. of nadolol was dissolved in 0.05 M NaOH in MeOH in contact withair, 0.05 M MeOH soln. of 0.5 equiv. of CuCl2*2H2O was added; soln. was filtered, H2O was added, ppt. was filtered off, washed with MeOH and dried at room temp., elem. anal.;45%
42200-33-9

nadolol

A

(2R,2S,2'S)-nadolol

B

(2S,2R,2'S)-nadolol

C

(2R,2S,2'R)-nadolol

D

(2S,2R,2'R)-nadolol

Conditions
ConditionsYield
With diethylamine In ethanol; n-heptane at 23℃; Resolution of racemate;

Nadolol Specification

The Nadolol, with the CAS registry number 42200-33-9, is also known as 2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, cis-. It belongs to the product categories of Amines; Aromatics; Intermediates & Fine Chemicals; Pharmaceuticals; Isotope Labelled Compounds. Its EINECS number is 255-706-3. This chemical's molecular formula is C17H27NO4 and molecular weight is 309.40. What's more, its systematic name is (2R,3S)-5-{2-Hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}-1,2,3,4-tetrahydro-2,3-naphthalenediol. Its classification codes are: (1)Adrenergic Agents; (2)Adrenergic Antagonists; (3)Adrenergic beta-antagonists; (4)Anti-adrenergic [beta-receptor]; (5)Anti-arrhythmia agents; (6)Antihypertensive agents; (7)Autonomic Agents; (8)Cardiovascular Agents; (9)Drug / Therapeutic Agent; (10)Human Data; (11)Neurotransmitter Agents; (12)Peripheral Nervous System Agents; (13)Reproductive Effect; (14)Sympatholytics. Nadolol is a non-selective beta blocker used in the treatment of high blood pressure, migraine headaches, and chest pain. It is polar and hydrophilic, with low lipid solubility.

Physical properties of Nadolol are: (1)ACD/LogP: 0.564; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -2.49; (4)ACD/LogD (pH 7.4): -1.54; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 5; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 81.95 Å2; (13)Index of Refraction: 1.574; (14)Molar Refractivity: 85.75 cm3; (15)Molar Volume: 260.026 cm3; (16)Polarizability: 33.994×10-24cm3; (17)Surface Tension: 46.64 dyne/cm; (18)Density: 1.19 g/cm3; (19)Flash Point: 272.179 °C; (20)Enthalpy of Vaporization: 84.297 kJ/mol; (21)Boiling Point: 526.437 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: OC(CNC(C)(C)C)COc1cccc2c1C[C@H](O)[C@H](O)C2
(2)Std. InChI: InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1
(3)Std. InChIKey: VWPOSFSPZNDTMJ-UCWKZMIHSA-N

The toxicity data is as follows:  

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral > 500mg/kg (500mg/kg)   Drugs in Japan Vol. -, Pg. 767, 1990.
man TDLo oral 571ug/kg (.571mg/kg) SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE Annals of Internal Medicine. Vol. 97, Pg. 454, 1982.
man TDLo oral 64mg/kg/4W-I (64mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF ENDOCRINE PANCREAS British Journal of Clinical Practice. Vol. 43, Pg. 74, 1989.
mouse LD50 intraperitoneal 270mg/kg (270mg/kg)   "Pharmacology of Antihypertensive Drugs," Scriabine, A., ed., New York, Raven Press, 1980Vol. -, Pg. 295, 1980.
mouse LD50 intravenous 47100ug/kg (47.1mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 1461, 1985.
mouse LD50 oral 3800mg/kg (3800mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ANTIPSYCHOTIC

LUNGS, THORAX, OR RESPIRATION: CYANOSIS		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 527, 1981.
mouse LD50 subcutaneous > 1gm/kg (1000mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 527, 1981.
rat LD50 intraperitoneal 322mg/kg (322mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 1461, 1985.
rat LD50 intravenous 59200ug/kg (59.2mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 16, Pg. 1461, 1985.
rat LD50 oral 5300mg/kg (5300mg/kg)   "Pharmacology of Antihypertensive Drugs," Scriabine, A., ed., New York, Raven Press, 1980Vol. -, Pg. 295, 1980.
rat LD50 subcutaneous > 1gm/kg (1000mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 527, 1981.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 42200-33-9